GSK
4 years ago ⋅ English ⋅ 11 min read
Newsroom
FDA grants accelerated approval for GSK’s JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancer

For media and investors only- GARNET study represents the largest dataset of anti-PD-1 monotherapy treatment of women with endometrial cancer- Study results showed an overall response r... Read More
GSK
4 years ago ⋅ English ⋅ 9 min read
Newsroom
GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19

For media and investors onlyIssued: London UK and San Francisco USGSK and Vir continue discussions with global regulators to make VIR-7831 available to patients with COVID-19.GlaxoSmith... Read More
GSK
4 years ago ⋅ English ⋅ 1 min read
Newsroom
GSK provides update on feladilimab, an investigational inducible T cell co-stimulatory (ICOS) agonist

GlaxoSmithKline plc today announced, following a recommendation by the Independent Data Monitoring Committee, that it has taken the decision to stop enrolling patients in the phase II I... Read More
GSK
4 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK announces Dr Anne Beal to join the Board as Non-Executive Director

For media and investors onlyGlaxoSmithKline plc (LSE/NYSE: GSK) today announces that Dr Anne Beal will join the Board of the Company as a Non-Executive Director with effect from 6 May 2... Read More
GSK
4 years ago ⋅ English ⋅ 7 min read
Newsroom
GSK to support manufacture of Novavax’ COVID-19 vaccine

For media and investors onlyIssued: London, UK, Gaithersburg, MD- GSK to support manufacture of up to 60 million doses of Novavax’ COVID-19 vaccine- Manufacturing to take place at... Read More
GSK
4 years ago ⋅ English ⋅ 13 min read
Newsroom
Lilly, Vir Biotechnology and GSK announce positive topline data from the phase 2 BLAZE-4 trial evaluating bamlanivimab with VIR-7831 in low-risk adults with COVID-19

For media and investors onlyIssued: London UK; San Francisco and Indianapolis US- In combination, the two monoclonal antibodies demonstrated a 70% relative reduction in persistently hig... Read More